Literature DB >> 23347648

Prevalence and epidemiological traits of HIV infections in populations with high-risk behaviours as revealed by genetic analysis of HBV.

Y Kojima1, T Kawahata, H Mori, K Furubayashi, Y Taniguchi, A Iwasa, K Taniguchi, H Kimura, J Komano.   

Abstract

The prevalence and epidemiological traits of human immunodeficiency virus (HIV)/hepatitis B virus (HBV) infections in high-risk populations (HRPs) remained unclarified in Japan. We determined the prevalence of HIV, HBV and Treponema pallidum (TP) and the viral genotypes in HRPs who attended primary sexually transmitted infection (STI) clinics in Osaka province during 2006-2011. Of 7898 specimens, 133 (1·7%) were HIV positive, which was significantly higher than the figures reported by Japanese Red Cross (0·0019%) and public health centres (0·27%) in Japan. The frequency of HIV-1 subtype B was 88·7%, followed by CRF01_AE (2·3%) and C (0·8%), which were almost identical to the national trend. HBV seroprevalence was surprisingly high in the HIV-positive group (63·2%), which was significantly higher than that in the HIV-negative group (25·6%). By contrast, there was no statistical correlation between HIV and TP infection. Interestingly, the distinct HBV genotypes Ae and G were prevalent in the HIV-positive population (60·0% and 20·0%, respectively), although both were rarely detected during nationwide surveillance. The transmission of HIV and HBV appeared to occur largely within a closed community early in life. Of note, about one-quarter of HIV-positive cases would have remained untested if health professionals had not motivated individuals to undergo HIV testing. This is the first evidence-based assessment of HIV positivity and HIV/HBV co-infection in HRPs at primary STIs in Japan and the effect of the involvement of health professionals in the diagnosis of HIV infections in asymptomatic carriers. The genotyping of HBV provided valuable information for understanding HIV epidemical traits.

Entities:  

Mesh:

Year:  2013        PMID: 23347648      PMCID: PMC9151427          DOI: 10.1017/S0950268812003123

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  40 in total

1.  Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection.

Authors:  Atsushi Ozasa; Yasuhito Tanaka; Etsuro Orito; Masaya Sugiyama; Jong-Hon Kang; Shuhei Hige; Tomoyuki Kuramitsu; Kazuyuki Suzuki; Eiji Tanaka; Shunichi Okada; Hajime Tokita; Yasuhiro Asahina; Kazuaki Inoue; Shinichi Kakumu; Takeshi Okanoue; Yoshikazu Murawaki; Keisuke Hino; Morikazu Onji; Hiroshi Yatsuhashi; Hiroshi Sakugawa; Yuzo Miyakawa; Ryuzo Ueda; Masashi Mizokami
Journal:  Hepatology       Date:  2006-08       Impact factor: 17.425

2.  Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.

Authors:  Yoshiyuki Suzuki; Mariko Kobayashi; Kenji Ikeda; Fumitaka Suzuki; Yasuji Arfase; Norio Akuta; Tetsuya Hosaka; Satoshi Saitoh; Masahiro Kobayashi; Takashi Someya; Marie Matsuda; Junko Sato; Sachiyo Watabiki; Yuzo Miyakawa; Hiromitsu Kumada
Journal:  J Med Virol       Date:  2005-05       Impact factor: 2.327

3.  Brief report: cerebral syphilitic gumma confirmed by the polymerase chain reaction in a man with human immunodeficiency virus infection.

Authors:  H W Horowitz; M P Valsamis; V Wicher; F Abbruscato; S A Larsen; G P Wormser; K Wicher
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

4.  The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state.

Authors:  N J Bodsworth; D A Cooper; B Donovan
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

5.  Hepatitis B virus genotype G is an extremely rare genotype in Japan.

Authors:  Hideaki Kato; Fuminaka Sugauchi; Atsushi Ozasa; Takanobu Kato; Yasuhito Tanaka; Hiroshi Sakugawa; Michio Sata; Keisuke Hino; Morikazu Onji; Takeshi Okanoue; Eiji Tanaka; Sumio Kawata; Kazuyuki Suzuki; Shuhei Hige; Tomoyoshi Ohno; Etsuro Orito; Ryuzo Ueda; Masashi Mizokami
Journal:  Hepatol Res       Date:  2004-12       Impact factor: 4.288

6.  Characteristics of hepatitis B virus isolates of genotype G and their phylogenetic differences from the other six genotypes (A through F).

Authors:  Hideaki Kato; Etsuro Orito; Robert G Gish; Fuminaka Sugauchi; Seiji Suzuki; Ryuzo Ueda; Yuzo Miyakawa; Masashi Mizokami
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

7.  Distinct geographic distributions of hepatitis B virus genotypes in patients with acute infection in Japan.

Authors:  Hiroshi Yotsuyanagi; Chiaki Okuse; Kiyomi Yasuda; Etsuro Orito; Shuhei Nishiguchi; Joji Toyoda; Eiichi Tomita; Keisuke Hino; Kiwamu Okita; Shiro Murashima; Michio Sata; Hiromi Hoshino; Yuzo Miyakawa; Shiro Iino
Journal:  J Med Virol       Date:  2005-09       Impact factor: 2.327

8.  Survival in patients with HIV infection and viral hepatitis B or C: a cohort study.

Authors:  Maurizio Bonacini; Stan Louie; Natalie Bzowej; Amy Rock Wohl
Journal:  AIDS       Date:  2004-10-21       Impact factor: 4.177

9.  Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection?

Authors:  Francesco Vitale; Fabio Tramuto; Ambrogio Orlando; Giovanni Vizzini; Valentina Meli; Giuseppe Cerame; Walter Mazzucco; Roberto Virdone; Ugo Palazzo; Maria Rosaria Villafrate; Alessandro Tagger; Nino Romano
Journal:  J Med Virol       Date:  2008-04       Impact factor: 2.327

10.  Effect of selective vaccination on a decrease in the rate of hepatitis B virus-positive Japanese first-time blood donors.

Authors:  A Yoshikawa; K Suzuki; A Abe; T Tanaka; K Yamaguchi; T Tanaka; Y Ishikawa; K Minegishi; Y Gotanda; H Yugi; S Uchida; M Satake; H Mizoguchi; K Tadokoro
Journal:  Transfus Med       Date:  2009-08       Impact factor: 2.019

View more
  7 in total

1.  Identification of Novel Recombinant Forms of Hepatitis B Virus Generated from Genotypes Ae and G in HIV-1-Positive Japanese Men Who Have Sex with Men.

Authors:  Yoko Kojima; Takuya Kawahata; Haruyo Mori; Keiichi Furubayashi; Yasushi Taniguchi; Ichiro Itoda; Jun Komano
Journal:  AIDS Res Hum Retroviruses       Date:  2015-05-04       Impact factor: 2.205

2.  HIV-1 genetic variants in the Russian Far East.

Authors:  Elena Kazennova; Vita Laga; Ilya Lapovok; Nataliya Glushchenko; Dmitry Neshumaev; Alexander Vasilyev; Marina Bobkova
Journal:  AIDS Res Hum Retroviruses       Date:  2014-05-15       Impact factor: 2.205

3.  Circulation of Distinct Treponema pallidum Strains in Individuals with Heterosexual Orientation and Men Who Have Sex with Men.

Authors:  Yoko Kojima; Keiichi Furubayashi; Takuya Kawahata; Haruyo Mori; Jun Komano
Journal:  J Clin Microbiol       Date:  2019-01-02       Impact factor: 5.948

4.  Phylogeography and evolutionary history of hepatitis B virus genotype F in Brazil.

Authors:  Francisco C A Mello; Oscar C Araujo; Barbara V Lago; Ana Rita C Motta-Castro; Marcia Terezinha B Moraes; Selma A Gomes; Gonzalo Bello; Natalia M Araujo
Journal:  Virol J       Date:  2013-07-16       Impact factor: 4.099

5.  Prevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta-analysis.

Authors:  Lucy Platt; Clare E French; Catherine R McGowan; Keith Sabin; Erin Gower; Adam Trickey; Bethan McDonald; Jason Ong; Jack Stone; Philippa Easterbrook; Peter Vickerman
Journal:  J Viral Hepat       Date:  2019-12-22       Impact factor: 3.728

Review 6.  Hepatitis B Virus Genotype G: The Odd Cousin of the Family.

Authors:  Natalia M Araujo; Carla Osiowy
Journal:  Front Microbiol       Date:  2022-03-31       Impact factor: 5.640

7.  Phylogenetic Analysis of Hepatitis B Virus Genotypes Circulating in Different Risk Groups of Panama, Evidence of the Introduction of Genotype A2 in the Country.

Authors:  Alexander A Martínez; Yamitzel Zaldívar; Griselda Arteaga; Zoila de Castillo; Alma Ortiz; Yaxelis Mendoza; Omar Castillero; Juan A Castillo; Juan Cristina; Juan M Pascale
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.